Investor profile
Exor Ventures
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Exor Ventures is the early-stage investment arm of Exor N.V., the Agnelli family's holding company. The team focuses on early-stage startups from Seed to Series B, connecting Exor back to its entrepreneurial roots and long history of innovation. As described in deal announcements, Exor Ventures seeks to discover 'exceptional founders who have the ambition to build great companies,' investing on a global basis across AI, deeptech, and mobility. Over seven years the team built a €640M portfolio of companies including Mistral AI, Brex, Qonto, Alan, Via, and Neuralink. In late 2024, Exor announced it would discontinue new Ventures activity and enter a monetisation phase, with the portfolio subsequently managed by former MD Noam Ohana through his spin-out firm Ora Global.
Notable quotes
“Exor Ventures focuses on early-stage startups from Seed to Series B, across AI, deeptech, and mobility. Over the last 7 years, they have invested in companies on a global basis, such as Mistral AI, Via, Brex, Qonto, Alan, and Neuralink, among others.”
“Exor Ventures focuses on early-stage startups from Seed to Series B, across AI, deeptech, and mobility… invested in leading companies on a global basis, such as Mistral AI, Via, Brex, Qonto, Alan, Neuralink.”
“The Ventures team invests in early-stage companies, connecting Exor back to its entrepreneurial roots and long history of innovation. The team focuses on discovering exceptional founders who have the ambition to build great companies.”
Recent investments
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Sequoia Capital | 3 |
| Korelya Capital | 2 |
| Index Ventures | 2 |
| Balderton Capital | 2 |
| CDP Venture Capital | 2 |
| Bpifrance | 2 |
Fit check
Is Exor Ventures a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit